Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014–2020)

Bălănescu Paul; Bălănescu Anca; Bălănescu Eugenia; Băicuş Cristian

doi:10.2478/rjim-2020-0037

Romanian Journal of Internal Medicine (Jun 2021)

Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014–2020)

Bălănescu Paul,
Bălănescu Anca,
Bălănescu Eugenia,
Băicuş Cristian

Affiliations

Bălănescu Paul: University of Medicine and Pharmacy Carol Davila, Internal Medicine Chair, Bucharest, Romania
Bălănescu Anca: University of Medicine and Pharmacy Carol Davila, Pediatrics Chair, Bucharest, Romania
Bălănescu Eugenia: Clinical Immunology Laboratory CDPC, Colentina Clinical Hospital, Bucharest, Romania
Băicuş Cristian: University of Medicine and Pharmacy Carol Davila, Internal Medicine Chair, Bucharest, Romania

DOI: https://doi.org/10.2478/rjim-2020-0037
Journal volume & issue: Vol. 59, no. 2
pp. 101 – 111

Abstract

Read online

Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by graduate cutaneous and tissue fibrosis development and irreversible fibroproliferative vascular changes.

Published in Romanian Journal of Internal Medicine

ISSN: 2501-062X (Online)
Publisher: Sciendo
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine
Website: https://sciendo.com/journal/RJIM

About the journal

Abstract

Keywords